NYSE:SYK

Stryker Stock Insider Trading

Healthcare > Medical - Devices

Buy SYK

*Your capital is at risk

$295.00

+1.70 (+0.580%)

At Close: Jun 03, 2026

Stryker Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -88.17. In total, the insiders bought 753.6K and sold 1.74M SYK shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-88.17
● Buy	753.6K shares
● Sell	1.74M shares
49% Buy Activity Weak Negative Correlation
Sell Signal Medium Confidence May 26, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -88.17. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 04, 2026 Buy	Employee Stock Option granted 02/04/2026 (right to buy) A-Award	King Debra See Remarks	Officer	3 992 Value: $1.44M
Feb 04, 2026 Buy	Common Stock A-Award	Berry William E Jr Vp, Chief Accounting Officer	Officer	797 Value: $287.4K
Feb 04, 2026 Sell	Common Stock S-Sale	Stryker Ronda E Director	Director	40 363 Value: $14.5M
Feb 04, 2026 Sell	Common Stock S-Sale	Stryker Ronda E Director	Director	14 673 Value: $5.27M
Feb 04, 2026 Sell	Common Stock S-Sale	Stryker Ronda E Director	Director	14 437 Value: $5.18M
Feb 04, 2026 Sell	Common Stock S-Sale	Stryker Ronda E Director	Director	25 220 Value: $9.11M
Feb 04, 2026 Sell	Common Stock S-Sale	Stryker Ronda E Director	Director	30 067 Value: $10.9M
Feb 04, 2026 Sell	Common Stock S-Sale	Stryker Ronda E Director	Director	20 395 Value: $7.41M
Feb 04, 2026 Sell	Common Stock S-Sale	Stryker Ronda E Director	Director	61 956 Value: $22.6M
Feb 04, 2026 Sell	Common Stock S-Sale	Stryker Ronda E Director	Director	29 110 Value: $10.6M
Feb 04, 2026 Sell	Common Stock S-Sale	Stryker Ronda E Director	Director	4 836 Value: $1.77M
Feb 04, 2026 Sell	Common Stock S-Sale	Stryker Ronda E Director	Director	6 783 Value: $2.50M
Feb 04, 2026 Sell	Common Stock S-Sale	Stryker Ronda E Director	Director	2 160 Value: $796.1K
Feb 04, 2026 Buy	Employee Stock Option granted 02/04/2026 (right to buy) A-Award	Berry William E Jr Vp, Chief Accounting Officer	Officer	2 391 Value: $862.7K
Feb 04, 2026 Buy	Employee Stock Option granted 02/04/2026 (right to buy) A-Award	Montagnino Kimberly Ann Vp, Chief Comm. Officer	Officer	1 830 Value: $660.3K
Feb 04, 2026 Buy	Employee Stock Option granted 02/04/2026 (right to buy) A-Award	Fink M Kathryn Vp, Chief Hr Officer	Officer	5 654 Value: $2.04M
Feb 04, 2026 Buy	Employee Stock Option granted 02/04/2026 (right to buy) A-Award	Menon Viju Group President	CEO / President	10 310 Value: $3.72M
Feb 04, 2026 Buy	Employee Stock Option granted 02/04/2026 (right to buy) A-Award	Wells Preston Wendell Vp, Chief Financial Officer	C-Suite Officer	11 974 Value: $4.32M
Feb 03, 2026 Buy	Employee Stock Option granted 02/10/2016 (right to buy) M-Exempt	Stiles Spencer S President And COO	CEO / President	13 840 Value: $1.34M
Feb 03, 2026 Sell	Common Stock F-InKind	Stiles Spencer S President And COO	CEO / President	7 692 Value: $2.83M
Feb 03, 2026 Buy	Common Stock M-Exempt	Stiles Spencer S President And COO	CEO / President	13 840 Value: $1.34M
Feb 02, 2026 Buy	Employee Stock Option granted 02/10/2016 (right to buy) M-Exempt	Pierce James Andrew Group President	CEO / President	13 840 Value: $1.34M
Feb 02, 2026 Sell	Common Stock S-Sale	Pierce James Andrew Group President	CEO / President	475 Value: $175.2K
Feb 02, 2026 Sell	Common Stock F-InKind	Pierce James Andrew Group President	CEO / President	8 432 Value: $3.12M
Feb 02, 2026 Buy	Common Stock M-Exempt	Pierce James Andrew Group President	CEO / President	13 840 Value: $1.34M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT STRYKER CORPORATION

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and...

Read Full Profile Here